Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways, Cancer Genomics and Diagnostics, and melanin and skin pigmentation.
Focal Small Bowel FDG Uptake in Cancer Patients Undergoing PET/CT: Prevalence and Etiology.
Clinical validation of droplet digital PCR assays in detecting BRAFV600-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a double-blind, randomised phase 3 trial
Recent Developments in Targeting the Cell Cycle in Melanoma.
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma.
Supplementary Figures1 from Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma
Supplementary Data1 from Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma
Data from Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma
Early Detection and Prognostic Assessment of Cutaneous Melanoma
Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort
Cell-Free DNA in Dermatology Research
Patient- and County-Level Factors Associated with Late-Stage Merkel Cell Carcinoma at Diagnosis
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study
Impact of COVID-19 on melanoma diagnosis
Late-Stage Melanoma in New York State: Associations with Socioeconomic Factors and Healthcare Access at the County Level
Dermoscopy Proficiency Expectations for US Dermatology Resident Physicians
MC1R variants in relation to naevi in melanoma cases and controls: a pooled analysis from the M-SKIP project.
Melanoma origins: data from early-stage tumours supports de novo and naevus-associated melanomas as distinct subtypes.
Prognostic Gene Expression Profiling in Cutaneous Melanoma
Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition
Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition.
Technological advances for the detection of melanoma
TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors
TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors
Real-world outcomes of melanoma surveillance using the MoleMap NZ telemedicine platform
MC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: a pooled analysis from the M-SKIP project
Towards Automated Melanoma Detection With Deep Learning: Data Purification and Augmentation
Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy
<em>MC1R</em> variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project
Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma Samples
Mole Mapping for Management of Pigmented Skin Lesions